High-Throughput Screening Market Size, Share, Key Players and Future Scope
North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region. North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region.
BiotechnologyHigh-Throughput Screening Market Size,Share, Segment Analysis and ForecastReport 2024© P&S Intelligence. All rights reserved1
- Page 2 and 3: The global high-throughput screenin
- Page 4: Disclaimer:P&S Intelligence always
Biotechnology
High-Throughput Screening Market Size,
Share, Segment Analysis and Forecast
Report 2024
© P&S Intelligence. All rights reserved
1
The global high-throughput screening market is witnessing considerable
growth due to increasing geriatric population, increasing healthcare
expenditure, increasing research and development activities, launch of
technologically advanced products that are miniaturized and automated and
growing popularity of high-throughput screening for drug discovery.
Moreover, high adoption of high-throughput screening models in
pharmaceutical and biotechnology companies across the globe is supporting
the growth of the market. Based on technology, 2D cell culture segment is
expected to grow at the fastest rate during the forecast period owing to its
low cost and ease of use.
Request for sample copy of this report at:
https://www.psmarketresearch.com/market-analysis/high-throughputscreening-market/report-sample
The rapid growth in emerging economies and growing research and
development activities on stem cells and toxicology is expected to create
opportunities for the manufacturers of high-throughput screening products.
However, high cost of high-throughput screening, lack of trained
professionals and complexity in assay development are the key factors
hampering the growth of the global market.
Geographically, North America has been the largest market for highthroughput
screening, owing to its increased awareness, increasing
government funding, established healthcare industry, and easy accessibility
to advanced technologies due to the awareness in the region. The U.S.
contributed largest revenue to the North American as well as global highthroughput
screening market. The increased research and development
activities and increasing prevalence of chronic diseases arising the need for
novel treatments is the key growth driving factor for the U.S. highthroughput
screening market.
© P&S Intelligence. All rights reserved
2
Europe has been the second largest market for high-throughput screening,
where the market is driven by the presence of a large pool of patients,
increasing healthcare expenditure and rapidly developing healthcare
infrastructure. In 2015, Germany led the European high-throughput
screening market and it is also expected to grow at the fastest rate in Europe,
during forecast period. Globally, the high-throughput screening market is
expected to witness the fastest growth in Asia-Pacific during the forecast
period. The highest growth in the region is attributed to the increasing
research and development activities, increasing per capita income leading to
improving standard of living, increasing healthcare spending, growing
demand for better quality medical care, and awareness about highthroughput
screening in the region.
The key players operating in the global market are Agilent Technologies, Inc,
Danaher Corporation, Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad
Laboratories, Inc., Hamilton Company and Aurora Biomed, Inc.
Read More: https://www.psmarketresearch.com/market-analysis/highthroughput-screening-market
© P&S Intelligence. All rights reserved
3
Disclaimer:
P&S Intelligence always keeps its customers’ interests at the core while carrying out research
activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in
its market research publications. However, the information in publications is subject to fluctuations,
as it is based on primary interviews of officials from various companies or organizations. P&S
Intelligence is not responsible for any incorrect data provided by the key industry players of the
concerned domain. The information or analysis in P&S Intelligence publications represents opinions
based on research and should not be interpreted as statements of fact. Information in this report
was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence
does not endorse any product, service, or vendor depicted in its research publications.
All intellectual properties, including trademarks and copyrights, belong to their respective owners
and may be protected by copyright. Under no circumstance can these be reproduced in any form
without prior written agreement of their owners.
An order for market research report is intended for internal use of the company only and not for
disclosure to third parties or any other publication in general. No service, report, or part thereof
provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed,
circulated, or sublicensed in any medium or form now realized or hereafter become realized,
including but not limited to, all forms of optical-based media, magnetic, electronic, or digital,
without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.
Kindly write to: enquiry@psmarketresearch.com
B-13, Sector – 2, Noida, U.P. – 201301, INDIA
Contact No: +91 120 4541 337
US/Canada Toll-Free: 1-888-778-7886
© P&S Intelligence. All rights reserved
4